Saturday, 17 October 2026European Markets
ExploreSearch
ViaNews EU
stockMarket

CADELER Stock Bearish By 9% So Far On Tuesday

Loading stream...

(VIANEWS) - Shares of CADELER (Oslo Børs Benchmark Index_GI: CADLR.OL) slid 9.77% to kr38.40 at 14:26 EST on Tuesday, following the last session's downward trend. Oslo Børs Benchmark Index_GI is rising 0.12% to kr1,160.22, following the last session's upward trend. This seems, at the moment, a somewhat up trend exchanging session today.

About CADELER

Cadeler A/S operates as an offshore wind farm transportation and installation contractor in Denmark. The company also provides wind farm maintenance, construction, decommissioning, and other tasks within the offshore industry. It owns and operates two offshore jack-up windfarm installation vessels. The company was formerly known as Swire Blue Ocean A/S and changed its name to Cadeler A/S in October 2020. Cadeler A/S was founded in 2008 and is headquartered in Copenhagen, Denmark.

Earnings Per Share

As for profitability, CADELER has a trailing twelve months EPS of kr-10.43.

More news about CADELER (CADLR.OL).

Categories

stockMarket

Tags

Stock PricePrice DownMarket Session NowStock Price DownStock Market NowMarket SessionStock MarketStockCADELERCADLR.OL
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Autumn 2026 Governance Reshuffle: CEO Successions, Activist Settlements and Corporate Separations
Across sectors, boards are replacing or rotating leadership (Bausch + Lomb's abrupt CEO exit, Keyser's move to advisor, Deputy CEO promotions, Brown-Forman and BellRing successions). At the same time, activist pressure is being settled through cooperation agreements and board seats (Stride/Fivespan, Al Shams) and through structural separations (National Fuel's IUG spin-out, NGEx). The common thread is boards using governance levers such as new committees, advisory seats and planned succession to reset capital allocation and strategy. Public messaging stresses continuity and partnership, but the number of interim appointments and activist-driven changes points to underlying pressure.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,384 source documents archived
Query this data → isubstrate.com